Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

This study will evaluate the long-term safety of ARD103 cellular therapies

Participants needed: 49
Trial details
Biological sex: AllType: ObservationalSponsor: ARCE Therapeutics, Inc.Updated: Dec 8, 2025Locations: 3
Eligibility criteria

The participant has R/R AML or MDS and has previously received ARD103 CAR-T cell... [+1]

There are no specific exclusion criteria for this study

Status: Recruiting

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

This is a phase I/2, interventional, open-label, multicenter study to assess the safety and efficacy of ARD103 in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndrome.

Participants needed: 49
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: ARCE Therapeutics, Inc.Updated: Dec 10, 2025Locations: 3
Eligibility criteria

Documented diagnosis of AML with either refractory or relapsed disease or diagno... [+8]

Participants with acute promyelocytic leukemia [+7]